DalsnaFinance

DalsnaFinance › IPOs › Parabilis Medicines, Inc. › IPO

Parabilis Medicines, Inc. IPO

Completed

Parabilis Medicines, Inc. completed its initial public offering on Nasdaq on June 5, 2026.

Ticker	PBLS
Exchange	Nasdaq
Status	Completed
Listing date	June 5, 2026
Shares offered	33,500,000
Sector	Pharmaceutical Preparations

About Parabilis Medicines, Inc.

Parabilis Medicines, Inc. listed on Nasdaq on 2026-06-05.

Ingested from SEC EDGAR (424B4, 8-A12B), CIK 1657677.

Company coverage

Parabilis Medicines, Inc. — quote, profile and latest news →

Other recent IPOs

• First Breach, Inc. · August 12, 2026
• Advasa Holdings, Inc. · August 11, 2026
• Latigo Biotherapeutics, Inc. · August 4, 2026
• Obsidian Therapeutics, Inc. · August 3, 2026
• BOA Acquisition Corp. II · August 3, 2026
• Attovia Therapeutics, Inc. · July 29, 2026
• Game Your Game Inc. · July 27, 2026
• Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for Parabilis Medicines, Inc.. This page is general information, not investment advice.